Tumor-derived proteases like matrix metalloproteinases (MMPs), prostate-specific antigen (PSA), or urokinase-type plasminogen activator (uPA) contribute to the release of osteoblastic factors from the extracellular matrix, including TGF-β and IGF-I [30]. The gene discussed is PLAU; the disease is neoplasm.